Article PDF
References
Kohagura K, Higashiuezato Y, Ishiki T, et al: Plasma aldosterone in hypertensive patients on chronic hemodialysis: distribution, determinants and impact on survival. Hypertens Res 2006; 29: 597–604.
Diskin CJ, Stokes TJ, Dansby LM, Carter TB, Radcliff L : The clinical significance of aldosterone in ESRD: Part II. Nephrol Dial Transplant 2004; 19: 1331–1332; author reply 1332.
Fernandez RG, Leehan JA, Pastrana RF, Muniz RO : Effect of malnutrition on K+ current in T lymphocytes. Clin Diagn Lab Immunol 2005; 12: 808–813.
Schlaich MP, Schobel HP, Hilgers K, Schmieder RE : Impact of aldosterone on left ventricular structure and function in young normotensive and mildly hypertensive subjects. Am J Cardiol 2000; 85: 1199–1206.
Rocha R, Chander PN, Khanna K, Zuckerman A, Stier CT Jr : Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 1998; 31: 451–458.
Sato A, Funder JW, Saruta T : Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis. Am J Hypertens 1999; 12: 867–873.
Endemann DH, Touyz RM, Iglarz M, Savoia C, Schiffrin EL : Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 2004; 43: 1252–1257.
Sato A, Saruta T : Aldosterone-induced organ damage: plasma aldosterone level and inappropriate salt status. Hypertens Res 2004; 27: 303–310.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kohagura, K., Higashiuesato, Y., Ishiki, T. et al. Response to: The Contribution of Nutrition to the Protective Value of High Plasma Aldosterone Concentrations in Hemodialysis Patients. Hypertens Res 30, 752–754 (2007). https://doi.org/10.1291/hypres.30.752
Issue Date:
DOI: https://doi.org/10.1291/hypres.30.752